Pfizer Raises Annual Profit Forecast Amid Strong Sales of New Cancer Treatments and Heart Disease Drug
Pfizer raises its annual profit forecast, bolstered by new cancer treatments from its $43 billion Seagen deal and strong sales of heart disease drug Vyndaqel/Vyndamax. Quarterly sales grow 3%. Bollywood Fever: Pfizer, facing a...
